Breast Cancer

Post traumatic stress disorder can occur in women who've experienced the trauma of breast cancer.

This is my wish list for all cancer survivors across all types of cancer who struggle with cancer's emotional isolation.

Though it is a difficult subtype to treat right now, Cynthia Ma is optimistic about emerging treatment options for triple-negative breast cancer.

Barnes discusses discovering the value of inspiration in healing.

Knowing the possible risks for breast cancer is important, and some of them are within our control.

The FDA granted ribociclib a breakthrough therapy designation for some patients with breast cancer.

Breast cancer and melanoma survivor shares time management tips to fellow survivors.

AI therapy can put breast cancer survivors at risk for bone fractures, making bone density monitoring important.

In treating low-risk breast cancer, adding novel agents isn't always necessary, Hope S. Rugo says.

Time is limited and the time for experiences with loved ones is today, writes breast cancer survivor Barbara Tako.

Every day seems to link another food or behavior to my cancer diagnosis. Those endless recommendations sometimes just minimize what I am going through. Am I wrong to say enough is enough?

Kelly Kenzik, epidemiologist at the University of Alabama at Birmingham School of Medicine, discusses racial disparities between African American and white women with breast cancer.

A male breast cancer survivor looks for answers from those who know best.

The treatment landscape for triple-negative breast cancer is shifting as findings from trials continue to be explored.

Losing breasts is often difficult for women to accept.

Moaath K. Mustafa Ali, Cleveland Clinic, discusses the effects of smoking on breast cancer survivorship.

Neratinib reduced recurrence or death for some women with breast cancer, according to five-year data from a phase 3 trial.

Cancer is a great teacher of many valuable lessons.

Olga Ivanov talks with CURE about the multiple side effects, including changes in sex drive, that happen after women have risk-reducing surgery.

Another biosimilar for Herceptin proved to have similar outcomes as the original drug for patients with breast cancer in a phase 3 trial.

A lesson in the power of graciousness for the hardheaded cancer patient.